Lokcid Chewable Tabs
₹250.00
- Fast Acid Neutralisation: Powered by Shankh Bhasma to quickly counter excess stomach acid.
- Soothes Gastric Lining: Yashtimadhu Ghana helps calm irritation and supports gastric healing.
- Improves Digestion: Shivkshar Pachana Churna aids digestion and reduces bloating and flatulence.
- Easy Chewable Format: Chewable tablets ensure quicker relief and better patient compliance.
Key Benefits of Lokcid Chewable Tabs
Key Ingredients used in the Lokcid Chewable Tabs
Yashtimadhu Ghana
Soothes gastric mucosa
Shankh Bhasma
Natural antacid support
Shivkshar Pachana Churna
Improves digestion
Nishotha
Mild laxative aid
How to use the Lokcid Chewable Tabs
Chew 1–2 tablets after meals
Take three times daily
Or as directed by the physician
Healing journeys with AyurvedaOne: Customer Diaries
“Lokcid gives me quick relief from acidity after heavy meals. The chewable form works faster than anything I’ve tried. ”
“My frequent heartburn has reduced a lot. It feels gentle yet effective on my stomach. ”
“I used to suffer from bloating almost daily. Lokcid has really helped improve my digestion. ”
“The sour belching and discomfort are finally under control. Very convenient to take. ”
“I like that it’s Ayurvedic and easy to chew. Relief starts quickly after meals. ”
Related Products
Frequently Asked Questions
What is Lokcid used for?
Lokcid is used for the relief of acidity, heartburn, bloating, gas, and indigestion.
How does Lokcid work?
It works by neutralising excess acid, soothing the gastric lining, and improving digestion.
Is Lokcid fast acting?
Yes, its chewable formulation ensures quicker relief and better absorption.
How should Lokcid be taken?
Take 1–2 chewable tablets three times a day after meals or as directed by a physician.
Can Lokcid help with bloating and gas?
Yes, it helps reduce bloating, flatulence, and digestive discomfort.
Is Lokcid suitable for regular use?
It can be used as advised by a physician, especially for recurring acidity and indigestion.
Reviews
Clear filtersThere are no reviews yet.